A new understanding of Alzheimer’s disease is shaking up what many believed about how this devastating illness takes hold.

A new blood test for Alzheimer's disease has shown promise in accurately identifying people with early symptoms, according to ...

Research findings suggest that a new blood test for Alzheimer’s disease has shown promise in accurately identifying people ...

Cognito Therapeutics today announced new study results showing that its Spectris AD therapy significantly slows Alzheimer's ...

New peer-reviewed publication demonstrates that Spectris AD™ delays cognitive decline, brain atrophy, and functional loss in ...

Dr. Robert Holub, 41, left, recently joined the Alzheimer’s research practice of his father, Dr. Richard Holub, 77, ...

Scores of researchers have produced new tools that can deliver genes and selectively activate them in hundreds of different ...

Wednesday 11th June 2025, the Government delivered their Spending Review, providing insight into the UK Government's plans ...

Ixico said it was contracted by Fujirebio Diagnostics Inc, a Tokyo-based biomarker research company, to assist with the development of a new blood-based test for Alzheimer's disease called Lumipulse.

At a budget hearing, Sen. Collins criticized the Trump administration’s proposed NIH cuts, warning they could halt ...

We unveil medical developments from Belarusian scientists for the heart, calculating ageing, and identifying geneticsBelarusian ...